Skip Navigation


European Heart Journal Advance Access originally published online on April 5, 2007
European Heart Journal 2007 28(15):1805-1813; doi:10.1093/eurheartj/ehm065
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/15/1805    most recent
ehm065v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ferrario, M.
Right arrow Articles by Tavazzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrario, M.
Right arrow Articles by Tavazzi, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction

Maurizio Ferrario1,*, Margherita Massa2, Vittorio Rosti3, Rita Campanelli4, Marco Ferlini1, Barbara Marinoni1, Gaetano Maria De Ferrari5, Valentina Meli6, Mara De Amici6, Alessandra Repetto1, Anna Verri7, Ezio Bramucci1 and Luigi Tavazzi1

1 Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, P.le Golgi 2, 27100 Pavia, Italy
2 Biotechnology Laboratory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
3 Organ Transplantation Laboratory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4 Laboratory of Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
5 Intensive Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6 Pediatric Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7 Department of Applied and Behavioural Sanitary Science, University of Pavia, Pavia, Italy

Received 21 July 2006; revised 26 February 2007; accepted 8 March 2007; online publish-ahead-of-print 5 April 2007.

* Corresponding author. Tel: +39 0382 501598; fax: +39 0382 503159. E-mail address: m.ferrario{at}smatteo.pv.it

See page 1785 for the editorial comment on this article (doi:10.1093/eurheartj/ehm260)

Aims: We studied plasma erythropoietin (EPO) levels and their relation with CD34+VEGFR-2+ (mature and progenitor endothelial cells) and CD34+ CD133+VEGFR-2+, or CD34+ CD117+VEGFR-2+ (early/immature endothelial progenitors) cells in patients with acute myocardial infarction (AMI).

Methods and results: Fifty AMI patients undergoing percutaneous coronary intervention (PCI) within 6 h of symptom onset were enrolled. EPO, measured by ELISA, and cell subsets, by cytofluorimetric analysis, were evaluated before PCI, 24 h and 7 days afterwards. Forty-five healthy subjects (CTRLs) were studied. Plasma EPO levels were higher in AMI patients at admission, 24 h, and 7 days (P = 0.04, P = 0.0001, P = 0.001, respectively) than in CTRLs. No correlation was evidenced between EPO and haemoglobin (Hb) or haematocrit at admission or 24 h after AMI. Differently, both Hb and haematocrit inversely correlated with EPO at day 7 (P = 0.0016, P = 0.029, respectively). Plasma EPO levels correlated with CD34+CD133+VEGFR-2+ cells at day 7 (P = 0.03).

Conclusion: AMI patients have increased plasma EPO levels until day 7. In the early phase, plasma EPO levels are Hb-independent; at day 7, an Hb-modulated increase of EPO correlates with the percentage of CD34+CD133+VEGFR-2+ cells.

Key Words: Acute myocardial infarction • Erythropoietin • Vascular endothelial growth factor • Endothelial progenitors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Link between erythropoietin release and mobilization of endothelial progenitor cells in acute myocardial infarction
Wojciech Wojakowski, Maciej Kazmierski, Barbara Korzeniowska, and Michal Tendera
EHJ 2007 28: 1785-1786. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, and J. S. Dubiel
Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2265 - 2273.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. Wojakowski, M. Kazmierski, B. Korzeniowska, and M. Tendera
Link between erythropoietin release and mobilization of endothelial progenitor cells in acute myocardial infarction
Eur. Heart J., August 1, 2007; 28(15): 1785 - 1786.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.